CRO Expertise

Gene Therapy Overview

IVIS Imaging

Routes of Administration

Summary

Experience with multiple transgenic strains

Proficient with multiple dose administration methods

Established various in-vitro assays

IVIS imaging capabilities

White Papers

Selecting Proper Model GT Studies.pdf
ocular disease gene therapy
Gene_Therapies_for_Eye_Diseases.pdf
cancer gene+cell therapy
Gene & Cell Therapies for Cancer.pdf
cell+gene therapy
Gene and Cell Therapies for Rare Diseases.pdf
BLOG POST: Advances in Natural Killer Cell Therapies
BLOG POST: Two is better than one: Combination Gene Therapy
BLOG POST: Gene Therapy Approaches to Treat Uveitis

Webinars

Guangping Gao, University of Massachusetts Medical School – Gene Therapy for Rare Diseases – A New Paradigm in Medicine

Casey Maguire, Harvard Medical School – Strategies for in vivo Barriers to Gene Therapy Vectors

Jeffrey Vick, Chameleon Biosciences Inc. – Chameleon’s EVADER Technology: A more potent AAV vector with less immune response

Miguel Muñoz-Alía, Mayo Clinic – Retargeting and Shielding Measles Virus Vectors for Oncolytic Virotherapy

Molly Shoichet, University of Toronto – Regenerative Strategies in the Central Nervous System, Part One

Molly Shoichet, University of Toronto – Regenerative Strategies in the Central Nervous System, Part Two

Technical Sheet

Gene Therapy Overview

Articles

AAV-S: A versatile capsid variant for transduction of mouse and primate inner ear

Therapeutic efficacy in a hemophilia-B model

JOINN Locations

Joinn Locations